Our products are not for human consumption under any circumstances
In a large 56-week clinical trial that evaluated liraglutide in individuals who were overweight or had obesity, as well as had diabetes or prediabetes, participants reported statistically significant weight loss compared with those who took the placebo at the end of the study
A 4.5 on Trustpilot with a false-review warning, an F from the BBB, and genuinely split Reddit feedback dont paint a clear picture
The more you practice safe, comfortable injections, the more natural it will feel
Beyond the scale, the after picture includes an average 6.8 mmHg systolic blood pressure drop, a 28% reduction in triglycerides, improved sleep quality, and for those with type 2 diabetes, a 2.02% A1C reduction
Most GLP-1 side effects are gastrointestinal, mild, and improve within the first few weeks of each dose level Serious warning signs severe abdominal pain, persistent vomiting, or allergic reactions are rare but require immediate medical attention Wegovy, Zepbound, and Foundayo share a similar GI side-effect profile, with some differences in nausea and diarrhea frequency In-person monitoring at PEAK allows your clinician to catch issues early and adjust your titration schedule in real time Starting a GLP-1 medication like Wegovy (semaglutide), Zepbound (tirzepatide), or Foundayo (orforglipron) is a major step toward better health and it is completely normal to wonder what to expect along the way